Zydus Lifesciences unit recalls over 7000 bottles of overactive bladder drug Oxybutynin Chloride in US
The lot was produced at Ahmedabad and distributed in the US by Zydus Pharmaceuticals (USA) Inc, the US health regulator stated.
New Delhi: A unit of Zydus Lifesciences is recalling over 7,000 bottles of Oxybutynin Chloride tablets in the US due to manufacturing issues, according to the US Food and Drug Administration (USFDA).
Read also: Aurobindo Pharma, Sun Pharma recall Rasagiline Tablets, Cequa from US market
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian Pharmaceutical company headquartered in Ahmedabad. The Company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals. It is primarily engaged in the manufacture of generic drugs.
Read also: Zydus Healthcare gets CDSCO Panel Nod To Manufacture, Market Dydrogesterone Extended Release Table
